A 2025 study analyzing thousands of Reddit posts found that many symptoms are underreported in clinical trials but very real for users
Additional Research Areas Where Retatrutide May Benefit Phase 3 TRIUMPH trials study osteoarthritis, cardiovascular risk, kidney disease, and MASH
Physician supervision and pharmaceutical-grade sourcing ensure safe, effective outcomes
Bottom line The essence of microdosing semaglutide is to find the most effective, lowest dose for you, minimize side effects, and achieve lasting metabolic improvements
In the SURMOUNT trials for tirzepatide, researchers used an escalation starting at 2.5 mg weekly, increasing by 2.5 mg every four weeks until reaching the target maintenance dose (typically 5 mg, 10 mg, or 15 mg)